Content by The Scientist Marketing Team

Our panel of experts will share their perspectives on stem cell differentiation, including techniques for optimizing lineage specific differentiation.

The Scientist brings together a panel of experts to discuss the role of synergistic interactions.

The Scientist brings together a panel of experts to highlight some of the exciting areas where precision medicine is pushing the boundaries of science, technology, and therapy.

This webinar brings together a panel of experts to discuss how they are validating immunoassays for clinical use.

The Scientist brings together a panel of experts to discuss various microRNA functions.

The Scientist brings together a panel of experts to discuss challenges and strategies for optimizing your pluripotent stem cell culture.

This webinar will highlight new research on the human microbiome and how this knowledge is being used to understand health and disease.

The Scientist brings together a panel of experts to discuss strategies to study and characterize immune responses and highlight emerging bioanalytical techniques used for their assessment.

The Scientist brings together a panel of experts to discuss emerging technologies for studying protein-protein interactions.

This webinar brings together a panel of experts to discuss how they are using new technology to examine the molecular mechanism of cocaine addiction and to study the localization of proteins involved in small-molecule bioavailability.

The Scientist brings together a panel of experts to discuss advances in genetic engineering, focusing on innovations in synthetic biology and genome editing.

The Scientist brings together a panel of experts to discuss emerging technologies for studying complex biological interactions.

A survey of The Scientist readers identifies product trends and developments in laboratory shakers.

The Scientist brings together a panel of experts to discuss advances in quantitative PCR and emerging technologies, including digital PCR.

This webinar presents the path followed by Memorial Sloan Kettering Cancer Center (MSKCC) to develop a hybridization-based capture panel encompassing more than 300 key cancer-associated genes, which they have applied to characterize several thousand tumors.